Most recent posts

  XML Feeds

Search

Category: "Rebates"

03/23/19

  11:05:00 am, by MedBen5   , 217 words,  
Categories: News, Prescription, Transparency, Pharmacy benefit manager (PBM), MedBen Rx, Rebates

Rx Spending Hikes Call for Smart Solutions

In just four years, U.S. retail prescription drug spending grew nearly 27%... a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual… more »

02/23/19

  03:27:00 pm, by MedBen5   , 232 words,  
Categories: Prescription, Cost savings, Transparency, Specialty Drugs, MedBen Rx, Rebates

Government Fixes to Rx Prices a Slippery Slope

A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it's why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer… more »

01/13/19

  11:22:00 am, by MedBen5   , 217 words,  
Categories: Prescription, Discounts, Cost savings, Research, MedBen Rx, Rebates

Fight Back Against New Year’s Drug Price Increases

New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to… more »

12/30/18

  03:46:00 am, by MedBen5   , 357 words,  
Categories: Prescription, Discounts, Cost savings, MedBen Rx, Rebates

AWP Smoke and Mirrors

Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. Simply defined, the AWP is the average price that a pharmacy or other retailer pays a wholesaler for a drug. But as straightforward… more »

10/21/18

  08:47:00 pm, by MedBen5   , 221 words,  
Categories: Discounts, Online Services, Cost savings, Transparency, Legislation, MedBen Rx, Rebates

MedBen Rx Solutions Put Transparency Up Front

Drug pricing transparency is currently a hot government topic: On October 10, President Trump signed two bills designed to end the drug industry's "gag order" of pharmacists, which prevent them from discussing cheaper price options with consumers.… more »